Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine/Naloxone Stabilization for XR-NTX Induction
NCT02294253Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Sep 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Sep 2014; status: completed.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02294253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02294253.